Some Effects of Calcium on the Activation of Human Factor VIII/Von Willebrand Factor Protein by Thrombin
Open Access
- 1 October 1977
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 60 (4) , 819-828
- https://doi.org/10.1172/jci108836
Abstract
When Factor VIII/von Willebrand factor (FVIII/vWF) protein is rechromatographed on 4% agarose in 0.25 M CaCl2, the protein and vWF activity appear in the void volume, but most of the FVIII procoagulant activity elutes later. Recent evidence suggests that the delayed FVIII procoagulant activity is a proteolytically modified form of FVIII/vWF protein that filters anomalously from agarose in 0.25 M CaCl2. To test whether or not thrombin is the protease involved, the effect of 0.25 M CaCl2 on FVIII/vWF and its reaction with thrombin was examined. About 30% of the FVIII procoagulant activity was lost immediately when solutions of FVIII/vWF protein were made 0.25 M in CaCl2. When FVIII in 0.15 M NaCl was activated with 0.04 U thrombin/ml and then made 0.25 M in CaCl2, the procoagulant activity of a broad range of FVIII/vWF protein concentrations remained activated for at least 6 h. But, in 0.25 M CaCl2, the increase in FVIII procoagulant activity in response to thrombin was much more gradual and once activated, the procoagulant activity was stabilized by 0.25 M CaCl2. When thrombin-activated FVIII/vWF protein was filtered on 4% agarose in 0.15 M NaCl, there was considerable inactivation of FVIII procoagulant activity; however, the procoagulant activity that did remain eluted in the void volume. In contrast, when thrombin-activated FVIII/vWF protein was filtered in 0.25 M CaCl2, the FVIII procoagulant activity eluted well after the void volume and remained activated for 6 h. The procoagulant peak isolated by filtering nonthrombin-activated FVIII/vWF protein on agarose in 0.25 M CaCl2 was compared to that isolated from thrombin-activated FVIII/vWF protein. Both procoagulant activity peak proteins had about the same specific vWF activity as the corresponding void volume protein. Before reduction, the sodium dodecyl sulfate gel patterns for the two procoagulant activity peak proteins were the same. After reduction, the gel pattern for the nonthrombin-activated procoagulant activity peak protein contained bands of 195,000, 148,000-120,000, 79,000, 61,000, 51,000, and 18,000 daltons whereas the pattern for the reduced thrombin-activated procoagulant activity peak protein always lacked the higher molecular weight bands, but consistently showed the four lower molecular weight bands to be well resolved. Taken together, these results imply that thrombin generates the FVIII procoagulant activity that is stabilized by 0.25 M CaCl2 and elutes aberrantly from 4% agarose in that solvent.This publication has 32 references indexed in Scilit:
- Spontaneous aggregation of low molecular weight factor VIII and its prevention by 2mM CaCl2Thrombosis Research, 1976
- The Defect in Hemophilic and von Willebrand's Disease Plasmas Studied by a Recombination TechniqueJournal of Clinical Investigation, 1974
- Nature of von Willebrand Factor: A New Assay and a Specific InhibitorProceedings of the National Academy of Sciences, 1974
- Von Willebrand Factor: Dissociation from Antihemophilic Factor Procoagulant ActivityScience, 1973
- Defective Ristocetin-Induced Platelet Aggregation in von Willebrand's Disease and its Correction by Factor VIIIJournal of Clinical Investigation, 1973
- Quantitative Assay of a Plasma Factor Deficient in von Willebrand's Disease that is Necessary for Platelet Aggregation. RELATIONSHIP TO FACTOR VIII PROCOAGULANT ACTIVITY AND ANTIGEN CONTENTJournal of Clinical Investigation, 1973
- Plasma Aggregating Factor (Bovine) for Human Platelets: A Marker for Study of Antihemophilic and von Willebrand FactorsProceedings of the National Academy of Sciences, 1973
- The Subunit Structure of Normal and Hemophilic Factor VIIIJournal of Clinical Investigation, 1973
- Studies on the Nature of Antihemophilic Factor (Factor VIII)Journal of Clinical Investigation, 1973
- A study of the cation- and pH-dependent stability of factors V and VIII in plasma.1965